Trial
NCT04322396
Proactive Protection With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Chronic Obstructive Pulmonary Disease Trial Network, Denmark
Collaborators
—
Condition
Virus Diseases
Intervention
Azithromycin
Why stopped
Recommended by the DSMB
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-06-29